1. Home
  2. ATXS
  3. ATXS News

Latest Astria Therapeutics Inc. (ATXS) News on November 6, 2025

BioCryst (BCRX) Soars 6.1%: Is Further Upside Left in the Stock?
ATXS

Zacks

21 days ago

BioCryst (BCRX) Soars 6.1%: Is Further Upside Left in the Stock?

ATXS

MT Newswires

21 days ago

HC Wainwright Downgrades Astria Therapeutics to Neutral From Buy

Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX
ATXS

Zacks

22 days ago

Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX

BioCryst to buy Astria Therapeutics for $700m in enterprise value
ATXS

Pharmaceutical Technology

22 days ago

BioCryst to buy Astria Therapeutics for $700m in enterprise value

How the Astria Deal Is Shaping the New Story for BioCryst Pharmaceuticals
ATXS

Simply Wall St.

22 days ago

How the Astria Deal Is Shaping the New Story for BioCryst Pharmaceuticals

ATXS

MT Newswires

23 days ago

US Equity Markets Mixed After Fed Chair Hints at End of Quantitative Tightening Program

ATXS

MT Newswires

23 days ago

Sector Update: Health Care Stocks Higher Late Afternoon

ATXS

MT Newswires

23 days ago

Top Midday Decliners

ATXS

MT Newswires

23 days ago

Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday

ATXS

MT Newswires

23 days ago

Sector Update: Health Care

ATXS

MT Newswires

23 days ago

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Escalating US-China Trade Friction

3 Biotech Stocks That Could More Than Triple if Their Trials Succeed
ATXS

Barchart

a month ago

3 Biotech Stocks That Could More Than Triple if Their Trials Succeed

Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
ATXS

Business Wire

a month ago

Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting

ATXS

MT Newswires

a month ago

Astria Therapeutics Begins Phase 3 Navenibart Trial for Hereditary Angioedema; Shares Up Pre-Bell

Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
ATXS

Business Wire

a month ago

Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema

Astria Therapeutics, Inc. (ATXS) Now Trades Above Golden Cross: Time to Buy?
ATXS

Zacks

2 months ago

Astria Therapeutics, Inc. (ATXS) Now Trades Above Golden Cross: Time to Buy?

Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology & Inflammation Summit
ATXS

Business Wire

5 months ago

Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology & Inflammation Summit

Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress
ATXS

Business Wire

5 months ago

Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress
ATXS

Business Wire

5 months ago

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

5 months ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare Conference
ATXS

Business Wire

5 months ago

Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare Conference

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop
ATXS

Business Wire

5 months ago

Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
ATXS

Business Wire

5 months ago

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference

Here's Why We're Not Too Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Situation
ATXS

Simply Wall St.

6 months ago

Here's Why We're Not Too Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Situation

Astria Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update
ATXS

Business Wire

6 months ago

Astria Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

6 months ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology
ATXS

Business Wire

6 months ago

Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology

Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference
ATXS

Business Wire

6 months ago

Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

7 months ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
ATXS

Business Wire

8 months ago

Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

8 months ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
ATXS

Business Wire

8 months ago

Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema

Astria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care Conference
ATXS

Business Wire

8 months ago

Astria Therapeutics to Present at Upcoming TD Cowen 45th Annual Health Care Conference

Calculating The Intrinsic Value Of Astria Therapeutics, Inc. (NASDAQ:ATXS)
ATXS

Simply Wall St.

8 months ago

Calculating The Intrinsic Value Of Astria Therapeutics, Inc. (NASDAQ:ATXS)

Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress
ATXS

Business Wire

9 months ago

Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

9 months ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics to Present at Upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference
ATXS

Business Wire

9 months ago

Astria Therapeutics to Present at Upcoming Oppenheimer 35th Annual Healthcare Life Sciences Conference

Astria Therapeutics to Present at Upcoming Western Society of Allergy, Asthma & Immunology Annual Scientific Session
ATXS

Business Wire

9 months ago

Astria Therapeutics to Present at Upcoming Western Society of Allergy, Asthma & Immunology Annual Scientific Session

Astria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0310, a Potential Best-in-Class Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis
ATXS

Business Wire

9 months ago

Astria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0310, a Potential Best-in-Class Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis

Astria Therapeutics Announces Design of ALPHA-ORBIT Pivotal Phase 3 Trial of Navenibart in HAE
ATXS

Business Wire

10 months ago

Astria Therapeutics Announces Design of ALPHA-ORBIT Pivotal Phase 3 Trial of Navenibart in HAE

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

10 months ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAE
ATXS

Business Wire

a year ago

Astria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAE

Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0310, a Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis
ATXS

Business Wire

a year ago

Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0310, a Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

a year ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
ATXS

Business Wire

a year ago

Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

a year ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting

Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting

Companies Like Astria Therapeutics (NASDAQ:ATXS) Are In A Position To Invest In Growth
ATXS

Simply Wall St.

a year ago

Companies Like Astria Therapeutics (NASDAQ:ATXS) Are In A Position To Invest In Growth

European Commission Grants Orphan Medicinal Product Designation for Navenibart, Astria Therapeutics’ Investigational Therapy for the Treatment of Hereditary Angioedema
ATXS

Business Wire

a year ago

European Commission Grants Orphan Medicinal Product Designation for Navenibart, Astria Therapeutics’ Investigational Therapy for the Treatment of Hereditary Angioedema

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

a year ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Receives FDA Orphan Drug Designation for Navenibart (STAR-0215) for the Treatment of Hereditary Angioedema
ATXS

Business Wire

a year ago

Astria Therapeutics Receives FDA Orphan Drug Designation for Navenibart (STAR-0215) for the Treatment of Hereditary Angioedema

Astria Therapeutics to Present at Upcoming Global Angioedema Forum
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming Global Angioedema Forum

Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

a year ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics to Present at Upcoming Bradykinin Symposium
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming Bradykinin Symposium

Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference
ATXS

Business Wire

a year ago

Astria Therapeutics to Participate in Upcoming Morgan Stanley 22nd Annual Global Healthcare Conference

Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
ATXS

Business Wire

a year ago

Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Astria Therapeutics Chooses Ypsomed’s YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary Angioedema
ATXS

Business Wire

a year ago

Astria Therapeutics Chooses Ypsomed’s YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary Angioedema

Astria Therapeutics to Participate in Upcoming 2024 Wedbush PacGrow Healthcare Conference
ATXS

Business Wire

a year ago

Astria Therapeutics to Participate in Upcoming 2024 Wedbush PacGrow Healthcare Conference

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

a year ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

a year ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities
ATXS

PR Newswire

a year ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

ATXS

Business Wire

a year ago

Form 8.3 - Darktrace plc

ATXS

Business Wire

a year ago

Form 8.3 - International Distribution Services plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win
ATXS

Reuters

a year ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect
ATXS

Investor's Business Daily

a year ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

ATXS

GlobeNewswire

a year ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina
ATXS

Business Wire

a year ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

ATXS

Business Wire

a year ago

Form 8.3 - International Paper Company

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses
ATXS

Investor's Business Daily

a year ago

IBD Stock Of The Day Meta Rolls Out New AI Tools For Businesses

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library
ATXS

Business Wire

a year ago

Credo AI Launches the World's Largest and Most Comprehensive AI Risk and Controls Library

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap
ATXS

Investor's Business Daily

a year ago

Dow Jones Futures: Apple AI Launch, Tesla Shareholder Meeting, Fed Rate 'Dot Plot' On Tap

EnviroGold Global Closes First Tranche of Private Placement
ATXS

GlobeNewswire

a year ago

EnviroGold Global Closes First Tranche of Private Placement

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)
ATXS

GuruFocus.com

a year ago

Insider Sale: Director Carol Lowe Sells Shares of EMCOR Group Inc (EME)

How markets digested hot jobs print: Top takeaways
ATXS

Yahoo Finance Video

a year ago

How markets digested hot jobs print: Top takeaways

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
ATXS

GlobeNewswire

a year ago

Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"
ATXS

PR Newswire

a year ago

SoCalGas Volunteers to Help Sort 1.8 Million Pounds of Food to Help Labor Community Services "Stamp Out Hunger"

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

a year ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming Eastern Allergy Conference

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress

We're Not Very Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Rate
ATXS

Simply Wall St.

a year ago

We're Not Very Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Rate

Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
ATXS

Business Wire

a year ago

Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update

Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
ATXS

Business Wire

a year ago

Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

2 years ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
ATXS

Business Wire

2 years ago

Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors

Chief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Inc (ATXS)
ATXS

GuruFocus.com

2 years ago

Chief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Inc (ATXS)

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

2 years ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
ATXS

Business Wire

2 years ago

Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE

Astria Therapeutics, Inc. (NASDAQ:ATXS) is favoured by institutional owners who hold 53% of the company
ATXS

Simply Wall St.

2 years ago

Astria Therapeutics, Inc. (NASDAQ:ATXS) is favoured by institutional owners who hold 53% of the company

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

2 years ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
ATXS

Business Wire

2 years ago

Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
ATXS

Business Wire

2 years ago

Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting

Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference
ATXS

Business Wire

2 years ago

Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ATXS

Business Wire

2 years ago

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ATXS

Reuters

2 years ago

UPDATE 1-Brazil's military reinforces border with Venezuela and Guyana due to Esequibo

Microsoft, Tesla, Netflix, and More: Big Names in the Market Worth Talking About
ATXS

Motley Fool

2 years ago

Microsoft, Tesla, Netflix, and More: Big Names in the Market Worth Talking About

Chuck Royce Bolsters Stake in Vishay Precision Group Inc
ATXS

GuruFocus.com

2 years ago

Chuck Royce Bolsters Stake in Vishay Precision Group Inc

Share on Social Networks: